MyFinsight
Home
Blog
About
Proceeds from the
issuance of common stock
$1,904,211
Net cash provided
(used in) by financing...
$1,817,155
(34021.13%↑ Y/Y)
Canceled cashflow
$87,056
Net decrease in
cash, cash...
-$92,657
(94.66%↑ Y/Y)
Canceled cashflow
$1,817,155
something is missing
$436,589
Prepaid expenses and
other current assets
-$79,879
(51.30%↑ Y/Y)
Depreciation and
amortization
$72,860
(-11.83%↓ Y/Y)
Payments for offering
costs related to...
$82,568
Tax withholding
payments or tax...
$4,488
(-16.22%↓ Y/Y)
Net cash used in
operating activities
-$1,896,539
(-10.59%↓ Y/Y)
Canceled cashflow
$589,328
Cash used in
investing activities
-$9,150
Effect of exchange rate
on changes on cash
-$4,123
(73.39%↑ Y/Y)
Net loss
attributable to common...
-$1,547,912
(12.14%↑ Y/Y)
Accounts payable and
other current...
-$626,991
(-356.02%↓ Y/Y)
Stock based
compensation
-$167,326
(-330.98%↓ Y/Y)
Amortization of right-of-use
operating lease asset
-$143,638
Purchases of property and
equipment
$9,150
Back
Back
Cash Flow
AETHLON MEDICAL INC (AEMD)
AETHLON MEDICAL INC (AEMD)
source: myfinsight.com